61 – 70 of 71
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients.
(
- Contribution to journal › Article
-
Mark
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review.
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Cerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: a 13-year cause-specific multivariate mortality study.
(
- Contribution to journal › Article
-
Mark
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
(
- Contribution to journal › Article
- 2013
-
Mark
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
(
- Contribution to journal › Article
-
Mark
Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies.
(
- Contribution to journal › Article
-
Mark
Plasma tau levels in Alzheimer's disease
(
- Contribution to journal › Letter
- 2011
-
Mark
Predictors of long-term cognitive outcome in Alzheimer's disease.
(
- Contribution to journal › Article
- 2010
-
Mark
A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease
(
- Contribution to journal › Article